Promising progress for new treatment of type 1 diabetes New research shows promising progress in the use of anti-inflammatory cytokine for treatment of type 1 diabetes. The study reveals that administration of interleukin-35 (a protein made by immune cells) to mice with type 1 diabetes, reverses or cures the disease by maintaining a normal blood glucose level and the immune tolerance.
Imbalance of cellular bioenergetics in pancreatic beta-cells links to type 2 diabetes While impaired activation of mitochondrial energy metabolism in the presence of glucose has been demonstrated in pancreatic beta-cells from patients with type 2 diabetes, the cause of this dysfunction has been unknown. New research shows that in patients with type 2 diabetes, the balance between supply and demand of the mitochondrial membrane potential is altered causing a decrease in the signaling that turns on insulin secretion.
'Dialing for Diabetes Control' helps urban adults lower blood sugar Periodic telephone counseling can be a highly effective, low-cost tool for lowering blood-sugar levels in minority, urban adults with uncontrolled diabetes. According to the Centers for Disease Control and Prevention more than 29 million Americans have diabetes. Black, Hispanic and American Indian/Alaska Native adults are about twice as likely to have diagnosed diabetes as non-Hispanic white adults.